Omeprazole/sodium bicarbonate + omeprazole magnesium + sodium bicarbonate
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Gastric Acid
Conditions
Gastric Acid, Human Experimentation
Trial Timeline
Apr 1, 2008 → Jun 1, 2008
NCT ID
NCT00674115About Omeprazole/sodium bicarbonate + omeprazole magnesium + sodium bicarbonate
Omeprazole/sodium bicarbonate + omeprazole magnesium + sodium bicarbonate is a phase 3 stage product being developed by Bayer for Gastric Acid. The current trial status is completed. This product is registered under clinical trial identifier NCT00674115. Target conditions include Gastric Acid, Human Experimentation.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00674115 | Phase 3 | Completed |
Competing Products
20 competing products in Gastric Acid